Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline Based Chemotherapy Regimens for Women with Node-Positive or High-Risk NodeNegative, HER2-Negative Breast Cancer.
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209